Biotronik INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$16Mgeneral payments (2019-2025)
$789Kresearch payments (2019-2025)
11,964clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $3.1M
2020 $1.4M
2021 $2.2M
2022 $3.8M
2023 $1.9M
2024 $1.4M
2025 $2.4M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Clinical Cardiac Electrophysiology $9.3M
Cardiovascular Disease $3.1M
Interventional Cardiology $1.8M
Internal Medicine $463K
Pain Medicine $139K
Advanced Heart Failure and Transplant Cardiology $104K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Chad Bonhomme Westfield, IN Clinical Cardiac Electrophysiology $897,309.60
Ron Waksman Washington, DC Interventional Cardiology $710,207.63
Gaurav Upadhyay Chicago, IL Clinical Cardiac Electrophysiology $272,354.29
Roderick Tung Chicago, IL Clinical Cardiac Electrophysiology $184,094.64
Larry Chinitz New York, NY Clinical Cardiac Electrophysiology $169,673.72
Dhanunjaya Lakkireddy Kansas City, KS Clinical Cardiac Electrophysiology $159,850.73
Luigi Di Biase Bronx, NY Cardiovascular Disease $141,705.97
Gregory Harris Greenville, NC Clinical Cardiac Electrophysiology $139,307.08
Samuel Asirvatham Rochester, MN Clinical Cardiac Electrophysiology $129,386.65
Jonathan Dukes Ventura, CA Clinical Cardiac Electrophysiology $129,358.25

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.